InsiderSource

Zaks Tal Zvi

Director, Chief Medical Officer · SEC CIK 1690927
Insider at TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD ADAP Adaptimmune Therapeutics PLC MRNA Moderna, Inc.
Advertisement

Buy track record

How this insider's open-market purchases have performed
This insider has no open-market purchases in the records we parsed, so there's no buy track record to score. Their full filing history is below.
Advertisement
Open-market buys
$0
0 trades
Open-market sells
$28.73M
157 trades
Net flow
−$28.73M
Net selling
Total filings
199
transactions shown

Full transaction history

All Form 4 activity across every company, newest first
View on SEC EDGAR ↗
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Feb 9, 2021 ΔOwn −13%

Zaks Tal Zvi sold $73.2K of MRNA, trimming their stake 13%.

−$73.2K
400 sh @ $183
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Feb 9, 2021 ΔOwn −51%

Zaks Tal Zvi sold $259.8K of MRNA, trimming their stake 51%.

−$259.8K
1,404 sh @ $185
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Feb 9, 2021 ΔOwn −41%

Zaks Tal Zvi sold $105.2K of MRNA, trimming their stake 41%.

−$105.2K
566 sh @ $186
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Feb 9, 2021 ΔOwn −100%

Zaks Tal Zvi sold $149.5K of MRNA, trimming their stake 100%.

−$149.5K
800 sh @ $187
MRNA
Moderna, Inc.
Option exercise Zaks Tal Zvi · Chief Medical Officer · Option exercise · filed Feb 2, 2021 ΔOwn NEW
+$61.1K
5,000 sh @ $12
Advertisement
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Feb 2, 2021 ΔOwn −8.0%

Zaks Tal Zvi sold $62.5K of MRNA, trimming their stake 8%.

−$62.5K
400 sh @ $156
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Feb 2, 2021 ΔOwn −17%

Zaks Tal Zvi sold $125.8K of MRNA, trimming their stake 17%.

−$125.8K
800 sh @ $157
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Feb 2, 2021 ΔOwn −11%

Zaks Tal Zvi sold $63.3K of MRNA, trimming their stake 11%.

−$63.3K
400 sh @ $158
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Feb 2, 2021 ΔOwn −24%

Zaks Tal Zvi sold $127.4K of MRNA, trimming their stake 24%.

−$127.4K
800 sh @ $159
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Feb 2, 2021 ΔOwn −12%

Zaks Tal Zvi sold $48.1K of MRNA, trimming their stake 12%.

−$48.1K
300 sh @ $160
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Feb 2, 2021 ΔOwn −13%

Zaks Tal Zvi sold $48.6K of MRNA, trimming their stake 13%.

−$48.6K
300 sh @ $162
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Feb 2, 2021 ΔOwn −15%

Zaks Tal Zvi sold $48.9K of MRNA, trimming their stake 15%.

−$48.9K
300 sh @ $163
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Feb 2, 2021 ΔOwn −35%

Zaks Tal Zvi sold $98.5K of MRNA, trimming their stake 35%.

−$98.5K
600 sh @ $164
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Feb 2, 2021 ΔOwn −18%

Zaks Tal Zvi sold $33.1K of MRNA, trimming their stake 18%.

−$33.1K
200 sh @ $165
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Feb 2, 2021 ΔOwn −11%

Zaks Tal Zvi sold $17.1K of MRNA, trimming their stake 11%.

−$17.1K
100 sh @ $171
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Feb 2, 2021 ΔOwn −88%

Zaks Tal Zvi sold $121K of MRNA, trimming their stake 88%.

−$121K
700 sh @ $173
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Feb 2, 2021 ΔOwn −100%

Zaks Tal Zvi sold $17.4K of MRNA, trimming their stake 100%.

−$17.4K
100 sh @ $174
MRNA
Moderna, Inc.
Option exercise Zaks Tal Zvi · Chief Medical Officer · Option exercise · filed Jan 26, 2021 ΔOwn NEW
+$61.1K
5,000 sh @ $12
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Jan 26, 2021 ΔOwn −4.0%

Zaks Tal Zvi sold $27.6K of MRNA, trimming their stake 4%.

−$27.6K
200 sh @ $138
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Jan 26, 2021 ΔOwn −4.2%

Zaks Tal Zvi sold $27.9K of MRNA, trimming their stake 4%.

−$27.9K
200 sh @ $139
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Jan 26, 2021 ΔOwn −17%

Zaks Tal Zvi sold $112.8K of MRNA, trimming their stake 17%.

−$112.8K
800 sh @ $141
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Jan 26, 2021 ΔOwn −11%

Zaks Tal Zvi sold $56.7K of MRNA, trimming their stake 11%.

−$56.7K
400 sh @ $142
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Jan 26, 2021 ΔOwn −47%

Zaks Tal Zvi sold $229.2K of MRNA, trimming their stake 47%.

−$229.2K
1,600 sh @ $143
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Jan 26, 2021 ΔOwn −44%

Zaks Tal Zvi sold $115.4K of MRNA, trimming their stake 44%.

−$115.4K
800 sh @ $144
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Jan 26, 2021 ΔOwn −60%

Zaks Tal Zvi sold $87.3K of MRNA, trimming their stake 60%.

−$87.3K
600 sh @ $145
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Jan 26, 2021 ΔOwn −100%

Zaks Tal Zvi sold $58.7K of MRNA, trimming their stake 100%.

−$58.7K
400 sh @ $147
MRNA
Moderna, Inc.
Option exercise Zaks Tal Zvi · Chief Medical Officer · Option exercise · filed Jan 20, 2021 ΔOwn NEW
+$61.1K
5,000 sh @ $12
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Jan 20, 2021 ΔOwn −6.7%

Zaks Tal Zvi sold $40.6K of MRNA, trimming their stake 7%.

−$40.6K
334 sh @ $122
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Jan 20, 2021 ΔOwn −28%

Zaks Tal Zvi sold $159.5K of MRNA, trimming their stake 28%.

−$159.5K
1,300 sh @ $123
MRNA
Moderna, Inc.
Sell Zaks Tal Zvi · Chief Medical Officer · Open-market sale · filed Jan 20, 2021 ΔOwn −30%

Zaks Tal Zvi sold $123.6K of MRNA, trimming their stake 30%.

−$123.6K
1,000 sh @ $124

Frequently asked questions

How is Zaks Tal Zvi's win rate calculated?

We take every open-market purchase (SEC code P) we can match to a stock price, then compare the split- and dividend-adjusted price on the purchase date to the most recent close. The win rate is the share of those buys currently trading above the purchase price. Sales and share grants are not scored.

Why are some buys not included in the score?

A purchase is excluded if we can't price it — for example if the ticker is missing from the filing, the company has been delisted, or the security isn't a common stock we can match to market data. Excluded counts are shown next to the scored total.

What do the 1M / 3M / 6M / 12M columns mean?

They show each purchase's return after a fixed holding period — one, three, six, and twelve months from the buy date — using split- and dividend-adjusted prices. This separates good entry timing from simply holding a long-running winner. A dash means that horizon hasn't elapsed yet for that trade, or the stock couldn't be priced at that date.

Does a high win rate mean I should copy this insider?

No. Past performance does not predict future results, sample sizes are often small, and an insider's edge in their own company doesn't transfer to yours. This is context, not a recommendation. InsiderSource is not investment advice.

Where does this data come from?

Trades come from Zaks Tal Zvi's SEC Form 4 filings on EDGAR. Prices come from public market data and are split/dividend-adjusted. Always verify against the original filings before acting.